Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.119.262238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Role of Glucagon-Like Peptide–2 Deficiency in Neonatal Short-Bowel Syndrome Using Neonatal Piglets

Pediatric Research
Child HealthPediatricsPerinatology
2013English

Orphan Designation: Human Glucagon-Like Peptide-2 Analogue Linked to a Human Immunoglobulin Fc Fragment, Treatment of Short Bowel Syndrome

Case Medical Research
2019English

Novel Mono-Lipidated Dimeric Glucagon-Like Peptide-1 Receptor Agonist With Improved Long-Acting and Hypoglycemic Activity

RSC Advances
ChemistryChemical Engineering
2019English

Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

A Biological Function for Glucagon-Like Peptide-2

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1998English

Elevated Plasma Glucagon-Like Peptide 1 and 2 Concentrations in Ileum-Resected Short Bowel Patients With a Preserved Colon

Gastroenterology
HepatologyGastroenterology
2000English

Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Gastroenterology
HepatologyGastroenterology
2019English

The Key Role of a Glucagon-Like Peptide-1 Receptor Agonist in Body Fat Redistribution

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

A Nonpeptidic Agonist of Glucagon-Like Peptide 1 Receptors With Efficacy in Diabeticdb/Dbmice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy